Table 4 Changes in echocardiographic parameters from baseline to 12 months in both groups
Δ, m-TOR group ( P) | Δ, Control group ( P) | Δ Effect (m-TOR vs Control) (95%CI) | P value | |
|---|---|---|---|---|
LAD (mm) | 0.90 ± 15 | 0.30 ± 14 | 0.59 ± 3.4 | 0.859 |
(0.4) | (0.6) | (-6 to 7.3) | ||
LVEDD (mm) | 45.8 ± 10 | 44 ± 9 | 1.8 ± 2.1 | 0.428 |
(0.7) | (0.2) | (-2.5 to 5.8) | ||
IVS (mm) | 5.3 ± 8.5 | 3.1 ± 16 | 2.2 ± 2.7 | 0.427 |
(0.002) | (0.04) | (-3.1 to 7.4) | ||
PWT (mm) | 7 ± 10 | 4.9 ± 14 | 2.1 ± 2.7 | 0.415 |
(0.001) | (0.01) | (-3.1 to 7.5) | ||
RWT | 4.8 ± 14 | 5 ± 17 | 0.2 ± 3.7 | 0.949 |
(0.026) | (0.035) | (-7.1 to 7.6) | ||
EF (%) | 6.6 ± 11 | 0.5 ± 16 | 6.1 ± 3.6 | 0.101 |
(0.7) | (0.2) | (-1.2 to 13) | ||
FS (%) | -1.05 ± 21 | -8 ± 25 | 7.1 ± 5.4 | 0.197 |
(0.2) | (0.02) | (-3.7 to 18) | ||
LVMi (g/m 2.7 ) | 8.4 ± 18 | 3.8 ± 16 | 4.5 ± 3.9 | 0.255 |
(0.003) | (0.052) | (-3.4 to 12) | ||
Peak E (cm/sec) | -19.4 ± 43 | -6.4 ± 25.6 | -13 ± 9 | 0.135 |
(0.034) | (0.4) | (-30 to 4.6) | ||
Peak A (cm/sec) | -11.1 ± 33 | -9.3 ± 27 | -1.7 ± 7 | 0.808 |
(0.3) | (0.1) | (-16 to 12) | ||
E/A ratio | -0.06 ± 0.34 | -0.001 ± 0.34 | -12.6 ± 9.8 | 0.429 |
(0.3) | (0.9) | (-32 to 7) | ||
DT (msec) | -18.2 ± 9 | -5 ± 40 | -13 ± 7.8 | 0.019 |
(0.05) | (0.8) | (-29 to 3.5) | ||
LVIRT (msec) | -10.3 ± 33 | -3 ± 31 | -7.1 ± 7.5 | 0.341 |
(0.4) | (0.5) | (-22 to 8) |